Lucid Diagnostics
LUCD
$0.68
Share price
0.60%
Change (1 day)
-53.53%
Change (1 year)
Categories
P/S ratio for Lucid Diagnostics (LUCD)
P/S ratio as of April 2024 (TTM): 13.6
According to Lucid Diagnostics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.5733. At the end of 2023 the company had a P/S ratio of 24.9.
P/S ratio history for Lucid Diagnostics from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 24.9 | -82.35% |
| 2022 | 141 | -64.31% |
| 2021 | 395 |